European Journal of Pharmaceutics and Biopharmaceutics 2014-10-01

Carboxymethylcellulose-tetrahydrocurcumin conjugates for colon-specific delivery of a novel anti-cancer agent, 4-amino tetrahydrocurcumin.

Thipapun Plyduang, Luelak Lomlim, Supreeya Yuenyongsawad, Ruedeekorn Wiwattanapatapee

文献索引:Eur. J. Pharm. Biopharm. 88(2) , 351-60, (2014)

全文:HTML全文

摘要

Several curcumin derivatives are now becoming increasingly of interest because of their bioactive attributes, especially their action as antioxidants and anti-carcinogenic activities. Tetrahydrocurcumin (THC), an active metabolite of curcumin, was selected to be a proper starting material for the work presented here as it is stable in physiological pH and has the typical pharmacological properties of curcumin. We have now reported that novel synthesized water-soluble polymeric macromolecule prodrugs can specifically deliver the drug to the colon. To study the drug loading and drug release, THC was conjugated with a hydrophilic polymer, carboxymethylcellulose (CMC) with the degree of substitution (DS) values of 0.7 and 1.2. THC was also attached to two different spacers including p-aminobenzoic acid (PABA) and p-aminohippuric acid (PAH) via an azo bond that was cleaved by the azoreductase activities of colonic bacteria. The novel active molecule, 4-amino-THC, was readily released from the conjugates in the colon (>62% within 24h) with only very small amounts released in the upper GI tract (<12% over 12h). The polymer conjugates showed chemical stability at various pH values along the gastrointestinal tract and increased water solubility of up to 5mg/mL. 4-Amino-THC demonstrated cytotoxic ability against the human colon adenocarcinoma cell lines (HT-29) with an IC50 of 28.67 ± 1.01 μg/mL, and even greater selectivity (∼ 4 folds) to inhibit HT-29 cells than to normal human colon epithelial cell lines while curcumin was a non-selective agent against both cell lines. Our study has demonstrated that the use of THC-CMC conjugates may be a promising colon-specific drug delivery system with its sustained release in the colon to be an effective treatment for colonic cancer.Copyright © 2014 Elsevier B.V. All rights reserved.


相关化合物

  • 盐酸
  • 二甲基亚砜
  • 4-氨基马尿酸
  • 1-(3-二甲基氨基丙...
  • N-Boc-1,6-二氨基...
  • 对氨基苯甲酸钠
  • 氯化氢甲醇溶液
  • 8-辛酰氧基芘-1,3,6...
  • 2-肟氰乙酸乙酯

相关文献:

Aptamer-based polyvalent ligands for regulated cell attachment on the hydrogel surface.

2015-04-13

[Biomacromolecules 16(4) , 1382-9, (2015)]

Assembly and structure of Lys33-linked polyubiquitin reveals distinct conformations.

2015-04-15

[Biochem. J. 467(2) , 345-52, (2015)]

Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf.

2015-05-01

[Biochem. J. 467(3) , 425-38, (2015)]

Fine mapping and characterization of the L-polymerase-binding domain of the respiratory syncytial virus phosphoprotein.

2015-04-01

[J. Virol. 89(8) , 4421-33, (2015)]

DNase II-dependent DNA digestion is required for DNA sensing by TLR9.

2015-01-01

[Nat. Commun. 6 , 5853, (2015)]

更多文献...